EPO antibody
Quick Overview for EPO antibody (ABIN7670596)
Target
See all EPO AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Purpose
- Erythropoietin/EPO Monoclonal Antibody(Capture)
-
Purification
- Protein A/G Purification
-
Immunogen
- Recombinant Mouse Erythropoietin/EPO protein expressed by E.coli
-
Isotype
- IgG2a
-
-
-
-
Application Notes
- ELISA Capture 2-8 μg/mL
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1 mg/mL
-
Buffer
- Sterile PBS , pH 7.4
-
Preservative
- Without preservative
-
Handling Advice
- Avoid freeze / thaw cycles. This preparation contains no preservatives, thus it should be handled under aseptic conditions.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store at 4°C Valid for 1 month or -20°C Valid for 12 months
-
Expiry Date
- 12 months
-
-
- EPO (Erythropoietin (EPO))
-
Alternative Name
- Erythropoietin/EPO
-
Target Type
- Hormone
-
Background
- MGC,ECYT,MVCD,Hematopoietin,Hemopoietin,ECYT5,EP,epoetin,Erythropoietin,MGC138142,MVCD2,Epo,This gene encodes a secreted, glycosylated cytokine composed of four alpha helical bundles. The encoded protein is mainly synthesized in the kidney, secreted into the blood plasma, and binds to the erythropoietin receptor to promote red blood cell production, or erythropoiesis, in the bone marrow. Expression of this gene is upregulated under hypoxic conditions, in turn leading to increased erythropoiesis and enhanced oxygen-carrying capacity of the blood. Expression of this gene has also been observed in brain and in the eye, and elevated expression levels have been observed in diabetic retinopathy and ocular hypertension. Recombinant forms of the encoded protein exhibit neuroprotective activity against a variety of potential brain injuries, as well as antiapoptotic functions in several tissue types, and have been used in the treatment of anemia and to enhance the efficacy of cancer therapies.
-
UniProt
- P07321
-
Pathways
- JAK-STAT Signaling, Hormone Activity, Negative Regulation of intrinsic apoptotic Signaling, Negative Regulation of Transporter Activity
Target
-